Anti-AVR2B/ ACVR2B/ ACTRIIB monoclonal antibody

Anti-AVR2B/ ACVR2B/ ACTRIIB antibody for FACS & in-vivo assay

Target products collectionGo to ACVR2B/ACVR2B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T80338-Ab-1/ GM-Tg-hg-T80338-Ab-2Anti-Human ACVR2B monoclonal antibodyHuman
GM-Tg-rg-T80338-Ab-1/ GM-Tg-rg-T80338-Ab-2Anti-Rat ACVR2B monoclonal antibodyRat
GM-Tg-mg-T80338-Ab-1/ GM-Tg-mg-T80338-Ab-2Anti-Mouse ACVR2B monoclonal antibodyMouse
GM-Tg-cynog-T80338-Ab-1/ GM-Tg-cynog-T80338-Ab-2Anti-Cynomolgus/ Rhesus macaque ACVR2B monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T80338-Ab-1/ GM-Tg-felg-T80338-Ab-2Anti-Feline ACVR2B monoclonal antibodyFeline
GM-Tg-cang-T80338-Ab-1/ GM-Tg-cang-T80338-Ab-2Anti-Canine ACVR2B monoclonal antibodyCanine
GM-Tg-bovg-T80338-Ab-1/ GM-Tg-bovg-T80338-Ab-2Anti-Bovine ACVR2B monoclonal antibodyBovine
GM-Tg-equg-T80338-Ab-1/ GM-Tg-equg-T80338-Ab-2Anti-Equine ACVR2B monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T80338-Ab-1/ GM-Tg-hg-T80338-Ab-2; GM-Tg-rg-T80338-Ab-1/ GM-Tg-rg-T80338-Ab-2;
GM-Tg-mg-T80338-Ab-1/ GM-Tg-mg-T80338-Ab-2; GM-Tg-cynog-T80338-Ab-1/ GM-Tg-cynog-T80338-Ab-2;
GM-Tg-felg-T80338-Ab-1/ GM-Tg-felg-T80338-Ab-2; GM-Tg-cang-T80338-Ab-1/ GM-Tg-cang-T80338-Ab-2;
GM-Tg-bovg-T80338-Ab-1/ GM-Tg-bovg-T80338-Ab-2; GM-Tg-equg-T80338-Ab-1/ GM-Tg-equg-T80338-Ab-2
Products NameAnti-ACVR2B monoclonal antibody
Formatmab
Target NameACVR2B
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-ACVR2B benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    BiosimilarGMP-Bios-ab-069Pre-Made Bimagrumab biosimilar, Whole mAb, Anti-ACVR2B Antibody: Anti-ACTRIIB/ActR-IIB/HTX4 therapeutic antibody
    Target AntigenProducts DevelopingMulti-species AVR2B/ ACVR2B/ ACTRIIB VLP (virus-like particle) (Products Developing)
    CytokineGM-Tg-g-T80338-Ag-1activin A receptor, type IIB (ACVR2B) protein
    ORF Viral VectorpGMLPm003094mouse Acvr2b Lentivirus plasmid
    ORF Viral VectorpGMLPm003095mouse Acvr2b Lentivirus plasmid
    ORF Viral VectorvGMLPm003094mouse Acvr2b Lentivirus particle
    ORF Viral VectorvGMLPm003095mouse Acvr2b Lentivirus particle


    Target information

    Target IDGM-T80338
    Target NameACVR2B
    Gene ID93,11481,25366,696071,485590,101086087,282131,100053588
    Gene Symbol and Synonyms4930516B21Rik,ActR-IIB,ACTRIIB,ACVR2B,AI047905,HTX4
    Uniprot AccessionQ13705,P38445,Q95126
    Uniprot Entry NameAVR2B_HUMAN,AVR2B_RAT,AVR2B_BOVIN
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target, INN Index, Cytokine Target
    DiseaseN/A
    Gene EnsemblENSG00000114739
    Target ClassificationKinase

    The target: ACVR2B, gene name: ACVR2B, also named as ACTRIIB, ActR-IIB, HTX4. Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I (I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling; and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. Type II receptors are considered to be constitutively active kinases. This gene encodes activin A type IIB receptor, which displays a 3- to 4-fold higher affinity for the ligand than activin A type II receptor. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.